Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis
about
B cells as a therapeutic target in autoimmune diseaseThe Spectrum and Clinical Significance of Autoantibodies in Rheumatoid ArthritisImmunoglobulin heavy chain variable region gene replacement As a mechanism for receptor revision in rheumatoid arthritis synovial tissue B lymphocytesRheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.A novel immunoglobulin-immunoglobulin interaction in autoimmunity.Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis.Modulating co-stimulation: a rational strategy in the treatment of rheumatoid arthritis?Heteroclitic polyclonal and monoclonal anti-Gm(a) and anti-Gm(g) human rheumatoid factors react with epitopes induced in Gm(a-), Gm(g-) IgG by interaction with antigen or by nonspecific aggregation. A possible mechanism for the in vivo generation ofComplete sequence of the genes encoding the VH and VL regions of low- and high-affinity monoclonal IgM and IgA1 rheumatoid factors produced by CD5+ B cells from a rheumatoid arthritis patient.The history of pediatric rheumatology.Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis.The rheumatoid factor in serum and synovial fluidHistorical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor.Rheumatoid factors: clinical applications.Targeted therapies in rheumatoid arthritis: Focus on rituximab.Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritisAssociation of susceptible genetic markers and autoantibodies in rheumatoid arthritis.Cathepsin D agglutinators in rheumatoid arthritis. I. Increased CDA titers in serum and synovial fluid of patients with seropositive RA.Tissue antigens: autoantigens, alloantigens, xenoantigens and neoantigens.Multiplexed immunoassay for detection of rheumatoid factors by FIDISTM technology.Antiglobulins and human disease.Canine rheumatoid arthritis--a review and a case report.Molecular theology, immunophilosophy, and autoimmune disease. II. Speculation on the aetiology and pathogenesis of rheumatoid arthritis.Growth and development of rheumatology in the United States--a bicentennial report. Presidential address to the American Rheumatism Association.Ultrastructural and immunohistochemical contribution to the histogenesis of human cardiac myxoma.Diversification of the Ig variable region gene repertoire of synovial B lymphocytes by nucleotide insertion and deletion.rs2841277 (PLD4) is associated with susceptibility and rs4672495 is associated with disease activity in rheumatoid arthritis.Something in the Blood? A history of the autoimmune hypothesis regarding myasthenia gravis.Anaemia of chronic disease in rheumatoid arthritis. Raised serum interleukin-6 (IL-6) levels and effects of IL-6 and anti-IL-6 on in vitro erythropoiesis.Rheumatoid factors react with Fab fragments of monoclonal antibodies to herpes simplex virus types 1 and 2 Fc gamma-binding proteins.Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Demonstration by precipitation and immunofluorescence.Predominance of T cells in the lymphocytic infiltrates of synovial tissues in rheumatoid arthritis.Serologic evaluation of patients receiving procainamide.[Demonstration of circulating autoantibodies in progressive chronic hepatitis].Latex slide agglutination vs. ELISA system. Rheumatoid factor detection in inflamed human gingiva.STUDY OF RHEUMATOID FACTOR IN A NORMAL POPULATION.In-vivo nuclear localisation of human antinuclear antibodies in mice with carbon tetrachloride- and thioacetamide-induced hepatic necrosis.Immunochemical characteristics and rheumatoid factor inhibiting activity of enzymic subfragments from the C gamma3 homology region of human IgG.Hidden rheumatoid-factor in active seronegative rheumatoid arthritis.
P2860
Q24804504-51627D34-4517-4964-9704-772F41F5CF5EQ27023858-BEE4902C-F19F-47E4-9C41-405D60BAF9BEQ30942899-CA83579C-5708-42D1-B4F8-392CCBBE0BBAQ33224257-14A312C4-03A6-4FF2-BF6E-80B798E95887Q33320977-4E090264-0857-458D-BF4D-07F03A80436DQ34063418-8CF80483-B8D3-495D-A7E7-3E8510AD0DECQ36099553-ED631EF5-F3E3-4979-A30D-702B538DDCE9Q36227383-017F5DED-7DD2-4D7C-B5EF-06D07CB8C234Q36248082-F6B6D87E-90D1-45F4-ADB5-C0B2AC8E60D3Q36267743-FEBA844D-EF21-43AA-BA08-90ACBBA8A79EQ36565997-A4A8FDB6-854F-4396-94D5-0EF58344585EQ37017057-7C8BE5A7-4A7B-419F-96B8-4C27D55CBA37Q37272142-3F24998D-F56B-4DCE-873E-27B7C5F11ABBQ37353700-53B50173-E1BB-4C3A-98E6-1C93AC4F5ABCQ37586832-E70E0577-6D69-4198-84CB-0B2EBD82B4B9Q37624583-F9A4C5EA-28F8-4B06-808D-A189FE5DA265Q37715460-803E6F0B-64E0-4274-A935-772D5B757C30Q38246108-723934D2-B328-423F-BBB8-DBDEEAC88CECQ39440550-08FD19DA-9A0B-4EA3-ADF7-8F676918FEB3Q39659241-AE981F29-8950-4745-AE19-02B133D04E22Q39723359-6CEEA4B2-3E45-49E6-8353-04BCB1DB2C2DQ39866270-1F2FD84B-D80C-4B9D-A89F-041D93540C92Q39957700-7F6B4D4C-AF04-4135-8EF4-87DA56504D43Q40125033-9688D920-07F9-4960-8599-741913DEA572Q40808061-E05AF4F4-E395-4632-A0CD-E0713857E704Q41436301-FBD5C6E0-C9CC-40DD-821C-BE40651D5F7DQ42103357-78B3B95B-F92C-4EB7-959C-AC27EAFB79A0Q42244593-19C00D53-EA23-49D9-BC6E-0B79ABADA8C2Q43536092-8B862808-A87E-4108-82B8-C1DA73FAE735Q43555069-02CC9FA1-A27A-4D96-B179-855913656D4FQ43741265-0B921E0D-EC6D-49A3-A029-E7E64B9658FBQ44042718-C56961E6-BBAB-4256-9A6B-8F3F746535A6Q44224334-9F7E69B2-B5A4-42A2-9F0F-A2781DC1F8E1Q44555315-7F9607B1-0615-4DE4-967F-FBC501D316E0Q45020906-CB7DCF1C-CC6C-4629-B36E-B79E2180D756Q45385228-60933514-648E-4270-BB5A-A02ECBBC4F0CQ45979967-1A9A4A6F-BD0A-499C-9C5A-0CFB5E595B54Q47768663-6BA49F23-0977-4F7C-982A-E8AA00B46403Q47830454-6091BCFA-AF42-41E3-A71C-8838F099BEEBQ47906713-F408647A-7E45-46F5-ABB3-CCFD26EFF8A5
P2860
Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis
description
1948 nî lūn-bûn
@nan
1948 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1948 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1948年の論文
@ja
1948年論文
@yue
1948年論文
@zh-hant
1948年論文
@zh-hk
1948年論文
@zh-mo
1948年論文
@zh-tw
1948年论文
@wuu
name
Differential agglutination of ...... ents with rheumatoid arthritis
@ast
Differential agglutination of ...... ents with rheumatoid arthritis
@en
Differential agglutination of ...... ents with rheumatoid arthritis
@nl
type
label
Differential agglutination of ...... ents with rheumatoid arthritis
@ast
Differential agglutination of ...... ents with rheumatoid arthritis
@en
Differential agglutination of ...... ents with rheumatoid arthritis
@nl
prefLabel
Differential agglutination of ...... ents with rheumatoid arthritis
@ast
Differential agglutination of ...... ents with rheumatoid arthritis
@en
Differential agglutination of ...... ents with rheumatoid arthritis
@nl
P1476
Differential agglutination of ...... ents with rheumatoid arthritis
@en
P2093
P356
10.3181/00379727-68-16375
P407
P577
1948-05-01T00:00:00Z